1887
Volume 2021, Issue 3
  • ISSN: 1999-7086
  • EISSN: 1999-7094

Abstract

Hypertriglyceridemia-induced pancreatitis accounts for up to 15 % of all acute pancreatitis admitted to hospitals. It is important to diagnose the etiology to provide adequate and timely management of the case and reduce complications. Epidemiological and clinical data on hypertriglyceridemia-induced pancreatitis in the Intensive Care Unit (ICU) are scarce, especially in Middle Eastern countries. We are reporting a case series of 18 patients admitted managed in the ICU over a period of 10 months. All patients above 18 years of age were diagnosed with hypertriglyceridemia-induced pancreatitis admitted to the ICU and High Dependency Unit (HDU), were included. Our objectives were to characterize the clinical and epidemiological features of hypertriglyceridemia-induced pancreatitis (HTG-AP) and calculate the number of insulin infusion days required to manage HIP. Patients were mostly middle-aged males from different ethnicity. Most of the patients presented with abdominal pain elevated pancreatic enzymes, and triglyceride. The mean triglyceride level on admission was 15.68 mmol/L. Most clinical findings were resolved when the triglyceride level dropped to below 5.6 mmol/L within 3.5 days. All patients presented with mild forms of pancreatitis without major complications. Fifty percent of our patients showed radiological features of acute pancreatitis, but no one developed local complications. Our case series showed that hypertriglyceridemia is a common cause of acute pancreatitis in Qatar. Upon admission, the mean triglyceride level was 15.68 mmol/L and the cause of the hypertriglyceridemia was unclear but could be related to ethnicity. Patients were primarily managed with insulin therapy and supportive care. None of the patients developed any local complications such as necrotizing pancreatitis or abscess formation. Around 16% of the patients had systemic complications, which were managed successfully.

Loading

Article metrics loading...

/content/journals/10.5339/jemtac.2021.23
2021-10-22
2021-12-02
Loading full text...

Full text loading...

/deliver/fulltext/jemtac/2021/3/jemtac.2021.23.html?itemId=/content/journals/10.5339/jemtac.2021.23&mimeType=html&fmt=ahah

References

  1. Peery AF, Dellon ES, Lund J, Crockett SD, McGowan CE, Bulsiewicz WJ, et al. Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology. 2012; 143:(5):1179–87. e3.
    [Google Scholar]
  2. Berglund L, Brunzell JD, Goldberg AC, Goldberg IJ, Sacks F, Murad MH, et al. Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism. 2012; 97:(9):2969–89.
    [Google Scholar]
  3. Sandhu S, Al-Sarraf A, Taraboanta C, Frohlich J, Francis GA. Incidence of pancreatitis, secondary causes, and treatment of patients referred to a specialty lipid clinic with severe hypertriglyceridemia: a retrospective cohort study. Lipids in health and disease. 2011; 10:(1):157.
    [Google Scholar]
  4. Valdivielso P, Ramírez-Bueno A, Ewald N. Current knowledge of hypertriglyceridemic pancreatitis. European journal of internal medicine. 2014; 25:(8):689–94.
    [Google Scholar]
  5. Lindkvist B, Appelros S, Regnér S, Manjer J. A prospective cohort study on risk of acute pancreatitis related to serum triglycerides, cholesterol and fasting glucose. Pancreatology. 2012; 12:(4):317–24.
    [Google Scholar]
  6. Stefanutti C, Labbadia G, Morozzi C. Severe hypertriglyceridemia-related acute pancreatitis. Therapeutic Apheresis and Dialysis. 2013; 17:(2):130–7.
    [Google Scholar]
  7. Nawaz H, Koutroumpakis E, Easler J, Slivka A, Whitcomb DC, Singh VP, et al. Elevated serum triglycerides are independently associated with persistent organ failure in acute pancreatitis. American Journal of Gastroenterology. 2015; 110:(10):1497–503.
    [Google Scholar]
  8. Havel R. Pathogenesis, differentiation and management of hypertriglyceridemia. Adv Intern Med. 1969;15::117-54.
    [Google Scholar]
  9. Pedersen SB, Langsted A, Nordestgaard BG. Nonfasting mild-to-moderate hypertriglyceridemia and risk of acute pancreatitis. JAMA internal medicine. 2016; 176:(12):1834–42.
    [Google Scholar]
  10. Tariq H, Gaduputi V, Peralta R, Abbas N, Nayudu SK, Thet P, et al. Serum triglyceride level: a predictor of complications and outcomes in acute pancreatitis. Canadian Journal of Gastroenterology and Hepatology. 2016;2016.
    [Google Scholar]
  11. Rivellese AA, De Natale C, Di Marino L, Patti L, Iovine C, Coppola S, et al. Exogenous and endogenous postprandial lipid abnormalities in type 2 diabetic patients with optimal blood glucose control and optimal fasting triglyceride levels. The Journal of Clinical Endocrinology & Metabolism. 2004; 89:(5):2153–9.
    [Google Scholar]
  12. Goldberg IJ. Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. Journal of lipid research. 1996; 37:(4):693–707.
    [Google Scholar]
  13. Charlesworth A, Steger A, Crook MA. Acute pancreatitis associated with severe hypertriglyceridaemia; a retrospective cohort study. International Journal of Surgery. 2015 Nov 1;23::23–7.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.5339/jemtac.2021.23
Loading
/content/journals/10.5339/jemtac.2021.23
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error